text
"['\n1. 요약재무정보\n요약 연결,별도재무정보는 한국채택국제회계기준(K-IFRS) 작성기준에 따라 작성되었습니다.(1) 요약 연결재무정보\xa0\n(단위:천원)\n과\xa0 \xa0 \xa0 \xa0 \xa0 목\n제20기 3분기\n제19기(2018년)\n제18기(2017년)\n[유동자산]\n44,576,582\n41,734,769\n28,022,224\nㆍ매출채권및기타채권\n16,286,821\n8,225,764\n3,724,634\nㆍ재고자산\n5,809,542\n3,213,944\n8,038,867\nㆍ기타 유동자산\n22,480,219\n30,295,061\n16,258,723\n[비유동자산]\n75,115,213\n65,372,475\n21,420,296\nㆍ장기매출채권 및 기타채권\n-\n122,374\n122,008\nㆍ유형자산\n3,244,562\n3,495,560\n13,824,214\nㆍ기타의 비유동자산\n71,870,651\n61,754,541\n7,474,074\n자산\xa0 총계\n119,691,795\n107,107,244\n49,442,520\n[유동부채]\n33,180,105\n29,169,409\n17,760,320\n[비유동부채]\n14,978,320\n4,690,185\n1,339,983\n부채\xa0 총계\n48,158,425\n33,859,594\n19,100,303\n[납입자본]\n26,154,493\n22,274,896\n15,110,923\n[기타자본구성요소]\n56,902,426\n152,608,102\n136,709,521\n[결손금]\n(13,332,743)\n(107,381,159)\n(121,478,227)\n[비지배지분]\n1,809,195\n5,745,811\n-\n자본\xa0 총계\n71,533,370\n73,247,650\n30,342,217\n종속기업 등 투자주식 평가방법\n지분법\n지분법\n지분법\n2019.01.01~09.30\n2018.01.01~12.31\n2017.01.01~12.31\n매출액\n66,780,882\n47,375,134\n26,832,432\n계속영업이익(손실)\n(604,671)\n(8,756,238)\n(15,937,902)\n계속영업당기순이익(손실)\n(12,157,165)\n(14,015,782)\n(34,710,537)\n중단영업당기순이익(손실)\n-\n-\n(3,228,841)\n당기순이익(손실)\n(12,157,165)\n(14,015,782)\n(37,939,378)\n당기총포괄손익(손실)\n(12,140,978)\n(14,125,465)\n(37,925,181)\n지배기업소유주지분\n(12,219,222)\n(13,630,959)\n(37,925,181)\n비지배기업소유주지분\n78,244\n(494,506)\n-\n계속영업기본주당이익(손실)\n(249)\n(307)\n(2,261)\n중단영업기본주당이익(손실)\n-\n-\n(210)\n계속영업희석주당이익(손실)\n(249)\n(307)\n(2,261)\n중단영업희석주당이익(손실)\n-\n-\n(210)\n연결에 포함된 회사수(개)\n7\n5\n1\n연결대상회사는 다음과 같습니다.\n연도\n제20기 3분기(2019년)\n제19기(2018년)\n제18기(2017년)\n회사명\n(주)모제림(주)넥스트매치(주)메타랩스코스메틱(주)모릭랩스(주)메타약품METALABS HONGKONG LIMITEDMETA JAPAN\n(주)모제림(주)넥스트매치(주)엔씨엘바이오(주)메타랩스코스메틱(주)모릭랩스\nACREX CHINA INC.\n(2) 요약 별도재무정보\xa0\n(단위:천원)\n과\xa0 \xa0 \xa0 \xa0 \xa0 목\n제20기 3분기\n제19기(2018년)\n제18기(2017년)\n[유동자산]\n24,480,331\n26,774,402\n25,071,711\nㆍ매출채권및기타채권\n4,282,933\n2,074,177\n3,937,575\nㆍ재고자산\n3,077,057\n1,461,090\n8,038,867\nㆍ기타 유동자산\n17,120,341\n23,239,135\n13,095,269\n[비유동자산]\n80,710,441\n67,574,337\n21,420,296\nㆍ장기매출채권 및 기타채권\n-\n112,220\n122,008\nㆍ유형자산\n1,554,483\n1,118,336\n13,824,214\nㆍ무형자산\n17,406,153\n2,098,965\n33,973\nㆍ기타의 비유동자산\n61,749,805\n64,244,816\n7,440,101\n자산\xa0 총계\n105,190,772\n94,348,739\n46,492,007\n[유동부채]\n20,864,623\n24,605,922\n14,583,735\n[비유동부채]\n10,856,123\n473,222\n1,339,983\n부채\xa0 총계\n31,720,746\n25,079,144\n15,923,718\n[납입자본]\n26,154,493\n22,274,896\n15,110,923\n[기타자본구성요소]\n60,785,450\n152,737,297\n137,187,580\n[결손금]\n(13,469,917)\n(105,742,598)\n(121,730,213)\n자본\xa0 총계\n73,470,026\n69,269,595\n30,568,289\n종속ㆍ관계ㆍ공동기업\n원가법\n원가법\n원가법\n투자주식의 평가방법\n2019.01.01~09.30\n2018.01.01~12.31\n2017.01.01~12.31\n매출액\n16,301,855\n18,522,860\n27,205,729\n계속영업이익(손실)\n(3,280,127)\n(11,991,186)\n(15,564,604)\n계속영업당기순이익(손실)\n(13,950,955)\n(14,211,574)\n(34,788,494)\n중단영업당기순이익(손실)\n-\n2,580,846\n-\n당기순이익(손실)\n(13,950,955)\n(11,630,728)\n(34,788,494)\n당기총포괄손익(손실)\n(14,056,409)\n(12,218,471)\n(34,774,297)\n계속영업기본주당이익(손실)\n(286)\n(322)\n(2,266)\n중단영업기본주당이익(손실)\n-\n59\n-\n계속영업희석주당이익(손실)\n(286)\n(322)\n(2,266)\n중단영업희석주당이익(손실)\n-\n59\n-\n']"
